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Abstract
Introduction Loss of intestinal integrity has been implicated as
an important contributor to the development of excessive
inflammation following severe trauma. Thus far, clinical data
concerning the occurrence and significance of intestinal
damage after trauma remain scarce. This study investigates
whether early intestinal epithelial cell damage occurs in trauma
patients and, if present, whether such cell injury is related to
shock, injury severity and the subsequent inflammatory
response.
Methods Prospective observational cohort study in 96 adult
trauma patients. Upon arrival at the emergency room (ER)
plasma levels of intestinal fatty acid binding protein (i-FABP), a
specific marker for damage of differentiated enterocytes, were
measured. Factors that potentially influence the development of
intestinal cell damage after trauma were determined, including
the presence of shock and the extent of abdominal trauma and
general injury severity. Furthermore, early plasma levels of i-
FABP were related to inflammatory markers interleukin-6 (IL-6),
procalcitonin (PCT) and C-reactive protein (CRP).
Results Upon arrival at the ER, plasma i-FABP levels were
increased compared with healthy volunteers, especially in the
presence of shock (P < 0.01). The elevation of i-FABP was
related to the extent of abdominal trauma as well as general
injury severity (P < 0.05). Circulatory i-FABP concentrations at
ER correlated positively with IL-6 and PCT levels at the first day
(r2 = 0.19; P < 0.01 and r2 = 0.36; P < 0.001 respectively) and
CRP concentrations at the second day after trauma (r2 = 0.25;
P < 0.01).
Conclusions This study reveals early presence of intestinal
epithelial cell damage in trauma patients. The extent of intestinal
damage is associated with the presence of shock and injury
severity. Early intestinal damage precedes and is related to the
subsequent developing inflammatory response.
Introduction
Severe trauma and major surgery frequently result in the devel-
opment of inflammatory complications, including systemic
inflammatory response syndrome, sepsis, and organ failure.
These conditions are associated with a poor clinical prognosis
[1,2]. For many years, the gut has been an organ of interest in
the initiation and perpetuation of the inflammatory response
following trauma or surgery [3-6]. In a rodent model of hemor-
rhagic shock that resembles the clinical situation of severe
blood loss-induced splanchnic hypoperfusion, intestinal cell
damage developed within one hour after shock induction [7].
Enterocyte damage following shock was paralleled by disrup-
tion of tight junction complexes and subsequent failure of the
gut barrier. This resulted in translocation of luminal bacteria
and toxins into the gut wall, which has been associated with
the development of the inflammatory response [8-12]. Moreo-
ver, intracellular proteins that are released by damaged cells
may contribute to the unfolding systemic inflammatory
response by acting as damage-associated molecular patterns
[13-15].Page 1 of 7
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loss in the development of excessive inflammation following
trauma, it remains to be clarified whether intestinal damage is
present early after trauma in humans [16]. Some reports indi-
cate that gut permeability as measured by sugar absorption
tests is increased within 48 hours after trauma, which sug-
gests that the intestine is compromised [17,18]. However, it is
not resolved whether this is the cause or the consequence of
systemic inflammation. Data on the state of the gut early after
trauma are absent because the value of standard permeability
tests is limited in the first hours [19].
This study aimed to clarify the early presence of enterocyte
damage following trauma. To this end, on arrival at the emer-
gency room (ER) circulating intestinal fatty acid binding pro-
tein (i-FABP), a specific biomarker for damage of differentiated
enterocytes, was measured [20-24]. A second aim of this
study was to gain insight into the factors that influence the
development of intestinal cell damage following multiple trau-
mas, such as presence of shock and injury severity. In addition,
the relation between intestinal cell damage and the inflamma-
tory response to trauma was explored.
Materials and methods
Patient selection
This prospective observational cohort study was approved by
the Ethics Committee of J.W. Goethe University, performed in
accordance with the Declaration of Helsinki and reported fol-
lowing the STrengthening the Reporting of OBservational
studies in Epidemiology (STROBE) guidelines [25]. Informed
consent was obtained by all patients or their relatives.
Between April 2006 and December 2007, all trauma patients
between 18 and 65 years were included at admittance to the
ER. Exclusion criteria were burns, acute myocardial infarction,
chronic inflammatory diseases, and lethal injury, resulting in a
cohort of 96 patients.
Assessment of shock and injury severity
Upon arrival at the ER, vital parameters of all patients were
recorded. The shock index (SI) was calculated as a ratio
between the first heart rate and systolic blood pressure regis-
tered. A normal SI was defined as a ratio of 0.7 or less [26].
Next, each injury was assigned an abbreviated injury scale
(AIS) score ranging from 0 to 5. Each AIS score was allocated
to one of six body regions (head/neck, face, chest, abdomen,
extremities, and external) [27]. Of each body region, the high-
est AIS score was used. The injury severity score (ISS) was
determined by squaring and adding together the scores of the
three most severely injured body regions [28].
Blood processing and analysis
Blood was withdrawn on arrival at the ER and daily during the
patient's stay in the J.W. Goethe University Hospital until the
second day after trauma. Samples were collected in pre-
chilled EDTA vacuum tubes (BD vacutainer, Becton Dickinson
Diagnostics, Aalst, Belgium) and kept on ice. Blood was cen-
trifuged at 2000 g for 15 minutes at 4°C. The supernatant was
stored at -80°C until batch sample analysis. Blinded speci-
mens (n = 7) from trauma patients were used for duplicate
measurement of i-FABP levels. i-FABP was determined using
ELISA (kindly provided by Hycult Biotechnology, Uden, the
Netherlands). i-FABP levels were also determined in 57
healthy volunteers between 18 and 65 years. For statistical
analyses, the detection limit for i-FABP of 41 pg/mL was
adjusted to samples in which i-FABP was not detectable (ER:
2 samples, day 1: 7 samples, day 2: 17 samples; and control:
20 samples). In the first 68 trauma patients, sufficient plasma
was stored to study inflammatory parameters. Plasma concen-
trations of IL-6 were measured by ELISA (Diaclone, Hoelzel
Diagnostica, Cologne, Germany) and C-reactive protein
(CRP) using the Tina-quant CRP assay (Roche, Mannheim,
Germany). Procalcitonin (PCT) levels were detected using a
Kryptor-Assay (Brahms, Henningsdorf, Germany).
Statistical analysis
First, the plasma i-FABP levels of all trauma patients on admit-
tance and at days 1 and 2 were compared with healthy control
values. Next, the relation between i-FABP values and the pres-
ence of shock and extent of injury severity were studied (gen-
eral injury: ISS classified in five categories and abdominal
injury: AIS). IL-6, PCT, and CRP levels in plasma were meas-
ured to analyze the inflammatory response in relation to early
intestinal cell damage. A Kolmogorov-Smirnov test showed
that plasma concentrations of i-FABP and inflammatory mark-
ers were not Gaussian distributed. Kruskal-Wallis test was
used to analyze differences between groups with regard to the
presence of shock, injury severity, and inflammatory markers.
Mann-Whitney U test was used to compare separate groups.
Data are expressed as median, 25th and 75th percentiles, and
range in the figures and as median (range) in the text. A P value
below 0.05 was considered to indicate statistical significance.
After transformation of the data into natural logarithms, Spear-
man's correlation was used to assess the association between
i-FABP and peak inflammatory parameters. Prism 4.0 for Win-
dows (GraphPad Software Inc., San Diego, CA, USA) was
used for computations.
Results
Intestinal cell damage is increased in trauma patients 
arriving at the emergency room
The mean age of trauma patients (n = 96) was 40 years; 83%
was male. Blood samples at admission to the ER were col-
lected at a mean period of 85 minutes following trauma induc-
tion. Concentrations of i-FABP in trauma patients were
significantly increased in comparison with healthy controls
(303 (41 to 84,846) pg/mL vs. 87 (41 to 413) pg/mL; P <
0.001; Figure 1). i-FABP levels at ER were also elevated com-
pared with levels at day 1 (174 (41 to 1805) pg/mL; P <
0.001) and day 2 (103 (41 to 1049) pg/mL; P < 0.001). At
day 1, i-FABP concentrations were still increased comparedPage 2 of 7
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2 was not significantly increased compared with control values
(P = 0.21). Of all trauma patients at the ER, i-FABP levels of
89 patients (93% of all trauma patients) exceeded 87 pg/mL,
which is the median of i-FABP plasma concentration in healthy
controls.
The extent of intestinal cell damage is related to 
presence of shock and injury severity
To investigate the relation between hemodynamic stability and
intestinal cell damage, i-FABP concentrations in trauma
patients in shock were compared with patients without shock
(SI > 0.7 vs. ≤ 0.7, respectively). On admittance to the ER, the
SI was increased in 42% of the patients. Plasma i-FABP con-
centrations were significantly higher in patients with an ele-
vated SI in comparison with patients with a normal SI (455 (41
to 84,242) pg/mL vs. 259 (41 to 1957) pg/mL; P < 0.01) or
healthy controls (P < 0.01, Figure 2a). Also in trauma patients
with a SI in the normal range, i-FABP levels were elevated in
comparison to healthy controls (P < 0.01).
On admittance, the ISS of all patients was calculated and cat-
egorized. All ISS categories comprised 12 patients or more. i-
FABP levels in patients with high ISS scores (ISS 31 to 40
and 41 to 50) were significantly increased compared with ISS
0 to 10, 11 to 20, and 21 to 30 categories (428 (142 to
84,846) pg/mL and 682 (52 to 8206) pg/mL vs. 189 (41 to
735) pg/mL, 210 (58 to 1860) pg/mL and 235 (54 to 1957)
pg/mL, each P < 0.05; Figure 2b). In all ISS categories, intes-
tinal cell damage was increased compared with healthy con-
trols (P < 0.01).
Next, the severity of local abdominal trauma was assessed
using the AIS scores of the abdomen. Scores of 0 (no abdom-
Figure 1
Intestinal cell damage increased rapidly following severe trauma. 
Plasma intestinal fatty acid binding protein (i-FABP) in trauma patients 
at the emergency room (ER) was significantly higher compared with 
samples collected at day 1 († P < 0.001), day 2 and healthy controls 
(both * P < 0.001). i-FABP concentrations at day 1 were elevated in 
comparison with day 2 and controls (both * P < 0.001).
Figure 2
Early intestinal cell damage is related to presence of shock and the extent of injury s verity
extent of injury severity. (a) Plasma intestinal fatty acid binding protein 
(i-FABP) concentrations were significantly increased in patients with an 
elevated shock index (SI > 0.7) compared with patients with a normal 
SI (= 0.7) († P < 0.01) or healthy controls (* P < 0.01). Also in trauma 
patients with a normal SI, i-FABP levels were higher in comparison to 
healthy controls (* P < 0.01). (b) i-FABP concentrations in patients 
with an injury severity score (ISS) of more than 30 were significantly 
elevated compared with ISS of 30 categories or less († P < 0.05). 
Intestinal cell damage in all ISS categories was increased compared 
with healthy controls (* P < 0.01). (c) i-FABP levels in patients with 
severe abdominal trauma (abbreviated injury scale (AIS) = 3) were sig-
nificantly increased compared with patients without abdominal injury 
(AIS = 0; * P < 0.01) and healthy controls († P < 0.001). i-FABP levels 
in patients without abdominal trauma were significantly higher com-
pared with healthy controls († P < 0.001).Page 3 of 7
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occurred most frequently (n = 48, 21, and 14 patients, respec-
tively), whereas scores of 1, 2, and 5 were assigned less often
(n = 8, 1, and 4 patients, respectively). As the abdominal AIS
score of 2 was assigned only once, the i-FABP concentration
detected in this patient (783 pg/mL) was not used for statisti-
cal evaluation. Taken together, at the ER abdominal trauma
was diagnosed in 50% of the patients. i-FABP levels were sig-
nificantly increased in patients with serious, severe, and critical
abdominal injury (AIS 3: 364 (122 to 1194) pg/mL, AIS 4:
1185 (52 to 2753) pg/mL and AIS 5: 1806 (287 to 8206) pg/
mL) compared with patients without abdominal injury (AIS 0:
231 (41 to 84,846) pg/mL; all P < 0.01) and healthy controls
(all P < 0.001; Figure 2c). Interestingly, also i-FABP concen-
trations in patients without abdominal trauma were signifi-
cantly elevated compared with healthy controls (P < 0.001).
Remarkably elevated i-FABP values at admittance 
indicate abdominal emergencies
In a few patients extremely elevated i-FABP levels were meas-
ured, far exceeding the values of other patients (Figure 3).
Examination of the medical records revealed that the highest
10% of i-FABP values at ER belonged to patients with severe
abdominal trauma that required acute surgical intervention,
such as ruptures of the diaphragm, liver, and spleen. The high-
est i-FABP concentration (84,846 pg/mL) was measured in a
patient assigned an AIS score of 0 at ER admission who was
diagnosed at day 2 with intestinal perforation. In this patient, i-
FABP concentrations at day 1 and 2 were 1181 pg/mL and
175 pg/mL, respectively.
Intestinal mucosal cell damage correlates with the 
subsequent inflammatory response
Circulating levels of IL-6, PCT, and CRP were measured on
arrival at the ER and at the following days to explore the inflam-
matory response following trauma. Plasma IL-6 strongly
increased at the first day (0.11 (0.01 to 18.35) ng/mL vs. ER:
0.04 (0.00 to 5.16) ng/mL, P < 0.05) and remained elevated
at the second day (0.12 (0.00 to 11.37) ng/mL). Levels of PCT
were barely detectable on presentation (0.06 (0.02 to 1.06)
ng/mL), whereas elevated levels were measured at day 1 and
2 (0.22 (0.04 to 18.23) ng/mL and 0.22 (0.03 to 18.55) ng/
mL, each P < 0.001 to ER). Consecutive measurements of
acute phase protein CRP showed highest plasma values on
the second day post-trauma (1.21 (0.06 to 2.72) mg/mL) com-
pared with the first day (0.42 (0.05 to 1.57) mg/mL, P <
0.001) and to CRP concentrations on admittance (0.01 (0.00
to 0.28) mg/mL, P < 0.001; Figure 4a). Next we analyzed the
relation between intestinal cell damage and the development
of inflammation. Concentrations of i-FABP at admittance cor-
related positively with values of IL-6 (r2 = 0.19, P < 0.01; Fig-
ure 4b) and PCT (r2 = 0.36, P < 0.001, Figure 4c) on the first
day after trauma. Furthermore, early i-FABP levels correlated
with CRP in plasma at the second day (r2 = 0.25, P < 0.01;
Figure 4d).
Discussion
Compromised intestinal integrity is considered to contribute to
the inflammatory response to trauma [12]. This study sought
to clarify the occurrence of intestinal damage and thus com-
promised integrity in the direct phase following severe trauma.
Here, we showed presence of intestinal epithelial cell damage
in a cohort of 96 trauma patients on arrival at the ER.
In the current study, evidence for intestinal cell damage after
trauma was provided by increased plasma i-FABP levels. i-
FABP is a small intracellular protein (14 kD) solely expressed
in differentiated enterocytes of the small intestine and to a
lower extent in the colon [20,22,24]. Following cell damage, i-
FABP is released and readily detectable in circulation [22].
The fast clearance of FABP (T1/2 = 11 minutes) implies that
the enhanced plasma i-FABP levels reflect ongoing intestinal
damage in our study [29].
A strong increase of i-FABP was observed in trauma patients
in shock. In the setting of shock, blood flow to the splanchnic
region is hampered in favor of perfusion of vital organs such as
the brain [30,31]. Therefore, the finding that i-FABP release is
increased in shock is in line with studies that established
splanchnic hypoperfusion as a major cause of i-FABP release.
In a human model of gut ischemia and reperfusion, short-term
ischemia induced a strong increase of plasma i-FABP, paral-
leled by histological damage of the epithelial layer and break-
down of intestinal barrier [22]. Moreover, elevated i-FABP
levels were detected in settings of splanchnic hypoperfusion
during non-abdominal surgery and critically illness [23,32]. In
the present study shock was determined using the SI, which
is considered more sensitive for shock than standard vital
signs alone [26,33]. The observed mucosal epithelial damage
in this patient cohort stresses the importance of rapid and ade-
quate fluid administration after severe trauma [34].
Figure 3
Strongly elevated i-FABP levels at ER indicate major abdominal trauma requiring immediate surgery
requiring immediate surgery. The highest 10% of intestinal fatty acid 
binding protein (i-FABP) values at emergency room (ER) were found in 
patients with severe abdominal trauma requiring acute intervention, 
such as rupture of the intestine, diaphragm, kidney, liver, or spleen.Page 4 of 7
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patients with a normal SI, so the relation between intestinal
damage and other trauma characteristics was explored. The
ISS is a frequently used anatomical scoring system that corre-
lates linearly with mortality, morbidity, hospital stay, and other
measures of trauma severity [28]. In the current study, the
extent of intestinal cell damage was found to be related to the
ISS. It should be noted that the ISS is a composite of the
scores of six body regions, including the abdomen. As abdom-
inal trauma is a likely cause of intestinal cell damage, the rela-
tion between abdominal trauma and intestinal cell damage
was then investigated. Half of the patients included in this
study had trauma in the abdominal region, as determined using
the AIS score. The highest i-FABP levels after trauma were
detected in patients with severe abdominal trauma that
required acute surgical intervention, such as rupture of the
intestine, diaphragm, liver, and spleen. Further studies are
needed to explore the sensitivity and specificity of i-FABP as
an early marker for small intestinal organ damage following
trauma. In addition to accepted diagnostic tools such as com-
puted tomography, i-FABP assessment may help to detect
abdominal emergencies in the early phase after trauma and
support the decision to perform surgical intervention
[24,34,35] (Relja and colleagues, unpublished data). In con-
clusion, the extent of intestinal cell damage is related to shock,
ISS, and abdominal trauma.
In search for a potential role of the compromised gut in the
development of inflammation following trauma, the relation
between intestinal cell damage and the early inflammatory
response was investigated. i-FABP levels on arrival at the ER
correlated with concentrations at day 1 of IL-6, a potent
cytokine in the early post-injury immune response that was
identified as a useful predictor of complications as well as mor-
tality [36,37]. Furthermore, i-FABP levels strongly correlated
with day 1 plasma levels of PCT, an inflammation marker that
is used to distinguish septic from non-septic patients [38]. In
line, CRP concentrations at day 2 also correlated positively to
Figure 4
Intestinal mucosal cell damage after trauma correlates positively with the inflammatory responsei i l t  . (a) Peak concentrations of circulating IL-6 and pro-
calcitonin (PCT) were reached at the first day after trauma, whereas highest levels of C-reactive protein (CRP) were measured at the second day (all 
parameters: * P < 0.05 vs. emergency room (ER); † P < 0.001 vs. day 1). (b to d) i-FABP concentrations at ER correlated positively with peak con-
centrations of IL-6 (r2 = 0.19, P < 0.01), PCT (r2 = 0.36, P < 0.001), and CRP (r2 = 0.25, P < 0.01). All data are shown in natural logarithmic scale.Page 5 of 7
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age clearly precedes and is related to the subsequent inflam-
matory response to severe trauma. Further studies are
required to determine the causative involvement and predic-
tive value of early enterocyte damage and gut barrier loss in
the development of inflammatory complications.
The gut has long since been considered to play a role in the
pathophysiology of complications following trauma [3-6]. Clar-
ification of the role of the intestine in the development of
excessive inflammation after trauma is not only interesting from
an etiologic viewpoint, but may also contribute to the selection
of patients for novel therapeutic strategies directed at preser-
vation of intestinal integrity and attenuation of the inflammatory
response [39].
Conclusions
To the best of the authors' knowledge, this paper is the first to
show that a significant proportion of trauma patients rapidly
develops intestinal mucosal cell damage. The extent of intesti-
nal damage is readily detectable in blood withdrawn on pres-
entation at the ER. Circulatory concentrations of enterocyte
damage marker i-FABP are related to the presence of shock
and the extent of general injury as well as abdominal trauma,
indicating that the level of intestinal cell damage is determined
by both systemic and local factors. Moreover, early i-FABP val-
ues correlate positively with the inflammatory response that
develops in the days following trauma. Further studies are
needed to clarify the importance of early intestinal damage in
the pathophysiologic response to trauma and its diagnostic
and therapeutic implications.
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